135 related articles for article (PubMed ID: 8828622)
1. Psychosocial aspects in phenylketonuria.
Weglage J; Fünders B; Ullrich K; Rupp A; Schmidt E
Eur J Pediatr; 1996 Jul; 155 Suppl 1():S101-4. PubMed ID: 8828622
[TBL] [Abstract][Full Text] [Related]
2. Psychological and social findings in adolescents with phenylketonuria.
Weglage J; Fünders B; Wilken B; Schubert D; Schmidt E; Burgard P; Ullrich K
Eur J Pediatr; 1992 Jul; 151(7):522-5. PubMed ID: 1396915
[TBL] [Abstract][Full Text] [Related]
3. Personality characteristics in patients with phenylketonuria treated early.
Weglage J; Rupp A; Schmidt E
Pediatr Res; 1994 May; 35(5):611-3. PubMed ID: 8065846
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.
Bosch AM; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Koledova E; Benmedjahed K; Regnault A
Orphanet J Rare Dis; 2015 Jun; 10():80. PubMed ID: 26084935
[TBL] [Abstract][Full Text] [Related]
5. Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires.
Regnault A; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Benmedjahed K; Bosch AM
Orphanet J Rare Dis; 2015 May; 10():59. PubMed ID: 25958326
[TBL] [Abstract][Full Text] [Related]
6. [Phenylketonuria: illness experience and coping mechanisms].
Weglage J; Fünders B; von Teeffelen-Heithoff A; Ullrich K
Z Kinder Jugendpsychiatr; 1993 Sep; 21(3):156-62. PubMed ID: 8237123
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial functioning in children with phenylketonuria: Relationships between quality of life and parenting indicators.
Morawska A; Mitchell AE; Etel E; Kirby G; McGill J; Coman D; Inwood A
Child Care Health Dev; 2020 Jan; 46(1):56-65. PubMed ID: 31782540
[TBL] [Abstract][Full Text] [Related]
8. Food acceptance and neophobia in children with phenylketonuria: a prospective controlled study.
Evans S; Daly A; Chahal S; MacDonald J; MacDonald A
J Hum Nutr Diet; 2016 Aug; 29(4):427-33. PubMed ID: 26510709
[TBL] [Abstract][Full Text] [Related]
9. Behavioural and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and healthy controls.
Weglage J; Grenzebach M; Pietsch M; Feldmann R; Linnenbank R; Denecke J; Koch HG
J Inherit Metab Dis; 2000 Jul; 23(5):487-96. PubMed ID: 10947203
[TBL] [Abstract][Full Text] [Related]
10. [Psychosocial characteristics of phenylketonuric women: birth defect prevention].
Shiloh S; Amitay M; Aizin N; Normand M; Elitzur A; Hadar R; Cohen BE
Harefuah; 1992 Apr; 122(8):487-92, 552. PubMed ID: 1398312
[TBL] [Abstract][Full Text] [Related]
11. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study.
Demirdas S; Maurice-Stam H; Boelen CC; Hofstede FC; Janssen MC; Langendonk JG; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; de Vries M; Grootenhuis MA; Bosch AM
Mol Genet Metab; 2013; 110 Suppl():S49-56. PubMed ID: 24100246
[TBL] [Abstract][Full Text] [Related]
13. Emotional outcome of adolescents and young adults with early and continuously treated phenylketonuria.
Sullivan JE
J Pediatr Psychol; 2001 Dec; 26(8):477-84. PubMed ID: 11700332
[TBL] [Abstract][Full Text] [Related]
14. The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria.
Bosch AM; Tybout W; van Spronsen FJ; de Valk HW; Wijburg FA; Grootenhuis MA
J Inherit Metab Dis; 2007 Feb; 30(1):29-34. PubMed ID: 17160615
[TBL] [Abstract][Full Text] [Related]
15. PKU in adolescents: rationale and psychosocial factors in diet continuation.
Levy HL; Waisbren SE
Acta Paediatr Suppl; 1994 Dec; 407():92-7. PubMed ID: 7766970
[TBL] [Abstract][Full Text] [Related]
16. The impact of phenylketonuria on PKU patients' quality of life: Using of the phenylketonuria-quality of life (PKU-QOL) questionnaires.
Alptekin IM; Koc N; Gunduz M; Cakiroglu FP
Clin Nutr ESPEN; 2018 Oct; 27():79-85. PubMed ID: 30144897
[TBL] [Abstract][Full Text] [Related]
17. Screening for cognitive and social-emotional problems in individuals with PKU: tools for use in the metabolic clinic.
Waisbren S; White DA
Mol Genet Metab; 2010; 99 Suppl 1():S96-9. PubMed ID: 20123479
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial aspects of PKU: hidden disabilities--a review.
Gentile JK; Ten Hoedt AE; Bosch AM
Mol Genet Metab; 2010; 99 Suppl 1():S64-7. PubMed ID: 20123473
[TBL] [Abstract][Full Text] [Related]
19. Personality disorder in young women with treated phenylketonuria.
Waisbren SE; Zaff J
J Inherit Metab Dis; 1994; 17(5):584-92. PubMed ID: 7837765
[TBL] [Abstract][Full Text] [Related]
20. Phenylketonuria and some aspects of emotional development.
Hendrikx MM; van der Schot LW; Slijper FM; Huisman J; Kalverboer AF
Eur J Pediatr; 1994 Nov; 153(11):832-5. PubMed ID: 7843199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
